Literature DB >> 17655562

Predictors of course in obsessive-compulsive disorder: logistic regression versus Cox regression for recurrent events.

P T Kempe1, P van Oppen, E de Haan, J W R Twisk, A Sluis, J H Smit, R van Dyck, A J L M van Balkom.   

Abstract

OBJECTIVE: Two methods for predicting remissions in obsessive-compulsive disorder (OCD) treatment are evaluated. Y-BOCS measurements of 88 patients with a primary OCD (DSM-III-R) diagnosis were performed over a 16-week treatment period, and during three follow-ups.
METHOD: Remission at any measurement was defined as a Y-BOCS score lower than thirteen combined with a reduction of seven points when compared with baseline. Logistic regression models were compared with a Cox regression for recurrent events model.
RESULTS: Logistic regression yielded different models at different evaluation times. The recurrent events model remained stable when fewer measurements were used. Higher baseline levels of neuroticism and more severe OCD symptoms were associated with a lower chance of remission, early age of onset and more depressive symptoms with a higher chance.
CONCLUSION: Choice of outcome time affects logistic regression prediction models. Recurrent events analysis uses all information on remissions and relapses. Short- and long-term predictors for OCD remission show overlap.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17655562     DOI: 10.1111/j.1600-0447.2007.00997.x

Source DB:  PubMed          Journal:  Acta Psychiatr Scand        ISSN: 0001-690X            Impact factor:   6.392


  8 in total

1.  Trait anger, anger expression, and suicide attempts among adolescents and young adults: a prospective study.

Authors:  Stephanie S Daniel; David B Goldston; Alaattin Erkanli; Joseph C Franklin; Andrew M Mayfield
Journal:  J Clin Child Adolesc Psychol       Date:  2009-09

2.  The Netherlands Obsessive Compulsive Disorder Association (NOCDA) study: design and rationale of a longitudinal naturalistic study of the course of OCD and clinical characteristics of the sample at baseline.

Authors:  Josien Schuurmans; Anton J L M van Balkom; Harold J G M van Megen; Johannes H Smit; Merijn Eikelenboom; Danielle C Cath; Maarten Kaarsemaker; Desiree Oosterbaan; Gert-Jan Hendriks; Koen R J Schruers; Nic J A van der Wee; Gerrit Glas; Patricia van Oppen
Journal:  Int J Methods Psychiatr Res       Date:  2012-11-12       Impact factor: 4.035

3.  Predictors of treatment outcome in modular cognitive therapy for obsessive-compulsive disorder.

Authors:  Gail Steketee; Jedidiah Siev; Jeanne M Fama; Aparna Keshaviah; Anne Chosak; Sabine Wilhelm
Journal:  Depress Anxiety       Date:  2011-02-09       Impact factor: 6.505

4.  Evaluating the predictive validity of suicidal intent and medical lethality in youth.

Authors:  Jeffrey Sapyta; David B Goldston; Alaattin Erkanli; Stephanie S Daniel; Nicole Heilbron; Andrew Mayfield; S Lyn Treadway
Journal:  J Consult Clin Psychol       Date:  2012-01-16

5.  A 2-year prospective follow-up study of the course of obsessive-compulsive disorder.

Authors:  Jane L Eisen; Anthony Pinto; Maria C Mancebo; Ingrid R Dyck; Maria E Orlando; Steven A Rasmussen
Journal:  J Clin Psychiatry       Date:  2010-08       Impact factor: 4.384

6.  Integrating radiosensitive genes improves prediction of radiosensitivity or radioresistance in patients with oesophageal cancer.

Authors:  Qiuning Zhang; Zhitong Bing; Jinhui Tian; Xiaohu Wang; Ruifeng Liu; Yi Li; Yarong Kong; Yan Yang
Journal:  Oncol Lett       Date:  2019-04-10       Impact factor: 2.967

7.  Predictors of response to cognitive behaviour therapy for obsessive-compulsive disorder.

Authors:  Michael Kyrios; Celia Hordern; Daniel B Fassnacht
Journal:  Int J Clin Health Psychol       Date:  2015-08-10

8.  Early maladaptive schemas impact on long-term outcome in patients treated with group behavioral therapy for obsessive-compulsive disorder.

Authors:  Tor Sunde; Benjamin Hummelen; Joseph A Himle; Liv Tveit Walseth; Patrick A Vogel; Gunvor Launes; Vegard Øksendal Haaland; Åshild Tellefsen Haaland
Journal:  BMC Psychiatry       Date:  2019-10-26       Impact factor: 3.630

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.